Health Condition 1: N182- Chronic kidney disease, stage 2 (mild) Health Condition 2: N183- Chronic kidney disease, stage 3 (moderate)
Conditions
Interventions
Intervention1: Standard care along with Active homeopathic medicine in CH-potency plus dummy LM potency: The medicines in CH potencies shall be procured from Good Manufacturing Practices certified com
Sponsors
Central Council for Research in Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: Both genders. Age 18 years to 70 years. Stage II with 60-89 ml/min/1.73m2 or stage III with GFR 59-30 ml/min/1.73m2 of CKD as per Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. Albumin-to-creatinine ratio (ACR) more than or equal to 30mg/g [more than or equal to 3mg/mmol]. Written informed consent.
Exclusion criteria
Exclusion criteria: Pregnant or lactating women. Patients with acute kidney injury, polycystic kidney disease. Patients with self-reported systemic illnesses such as cancer/HIV/ Hepatitis-B /Auto-immune diseases. Serious health issues requiring urgent medical/supportive treatment. Patients on peritoneal dialysis, haemodialysis, or kidney transplantation and a GFR less than 29ml/(min 1.73 m2).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the changes in Serum Creatinine levels and eGFR valueTimepoint: Baseline, Month 1,2,3,4,5,6,7,8,9,10,11,12 | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients progressed to first dialysis stage and its progression time-periodTimepoint: Baseline to progression to first dialysis stage;Quality of life using KDQOL-SF 1.3 questionnaireTimepoint: Month 3, 6, 9, 12;Changes in urine albumin to creatinine ratioTimepoint: Baseline, Month 1,2,3,4,5,6,7,8,9,10,11,12 | — |
Countries
India
Contacts
Public ContactAbhijit Chakma
Central Council for Research in Homoeopathy
Outcome results
None listed